TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosis
Authors
Keywords
Experimental autoimmune encephalomyelitis, Inflammation, Demyelination, Remyelination, Neuroprotection, TrkB Signal Transduction, Central nervous system
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started